Vascular disease and stem cell therapies
Open Access
- 17 May 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in British Medical Bulletin
- Vol. 98 (1), 187-197
- https://doi.org/10.1093/bmb/ldr017
Abstract
Peripheral vascular disease is the leading cause of limb ischemia (LI). LI is manifested by claudication, ischemic rest pain, ulcers or gangrene. It is the result of peripheral arterial disease due to atherosclerosis. Over the last decade, several centers around the world have initiated clinical trials utilizing stem cells as a treatment for this disease. Published medical literature, clinical trials announced in clinical trials.gov and TCA cellular therapy experience. There is general agreement that stem cells are useful for LI. These arise from the type of cells, dose, route of administration and methods to evaluate efficacy. Growing evidence suggests that bone marrow derived-mesenchymal stem cells are as good as or superior to mononuclear cells, and a combination of both cell types may be even better. Based on current trials and publications, several promising biological products could become part of the therapeutic arsenal for LI. This may include combinations of more than one type of adult/induced pluripotent stem cells/embryonic stem cells, use of stem cells with growth factors or extracellular matrix molecules.Keywords
This publication has 36 references indexed in Scilit:
- Combination Stem Cell Therapy for the Treatment of Severe Limb Ischemia: Safety and Efficacy AnalysisAngiology, 2010
- Preventing Leg Amputations in Critical Limb Ischemia With Below-the-Knee Drug-Eluting Stents: The PaRADISE (PReventing Amputations using Drug eluting StEnts) TrialJournal of the American College of Cardiology, 2010
- Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemiaBone Marrow Transplantation, 2009
- Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemiaAmerican Heart Journal, 2008
- Long-term effects of repeated autologous transplantation of bone marrow cells in patients affected by peripheral arterial diseaseBone Marrow Transplantation, 2008
- Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (The TAM-PAD study)Clinical Research in Cardiology, 2007
- Prevention of Limb Amputation in Patients with Limbs Ulcers by Autologous Peripheral Blood Mononuclear Cell ImplantationTherapeutic Apheresis and Dialysis, 2005
- Therapeutic Angiogenesis by Autologous Bone Marrow Cell Implantation for Refractory Chronic Peripheral Arterial Disease Using Assessment of Neovascularization by 99mTc-Tetrofosmin (TF) Perfusion ScintigraphyCell Transplantation, 2004
- Clinical Application of Bone Marrow Implantation in Patients With Arteriosclerosis Obliterans, and the Association Between Efficacy and the Number of Implanted Bone Marrow CellsCirculation Journal, 2004
- Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trialThe Lancet, 2002